Federico Monzon retweeted
Thank you @ClinGenResource , @HeidiRehm, @UDNIss , #wilhelmFoundation @BaylorGenetics @H3Africa @Unikinrdc and all of you, not mentioned in this tweet, for your commitment to supporting the @ARDI_Africa
Very happy to announce that we have been awarded a #R01 grant by the #NIH @genome_gov to help advance genomic medicine through Rare Diseases research in Africa:
11 clinical sites,
1 mobile App, 1 EHR, 1 registry, 900 WGS analyzed in #DRC, +++ diversity in databases
++ partners
Federico Monzon retweeted
"The U.S. is once again facing a testing shortage, which will only be further exacerbated by FDA’s plans to pull what the agency deems to be “non-priority #COVID19 tests” off the market as early as February... Now is not the time to reduce laboratory capacity."
AMP statement on actions needed to address the spread of the #Omicron #COVID19 Variant in the U.S.
#molpath #IDTwitter #pathologists
Federico Monzon retweeted
Welcome to Day 2 of the #AMPath21 Digital Experience! Today, we look forward to sessions with @VanAllenLab & @AshAlizadeh, as well as corporate workshops with @PGDx_ @CanexiaHealth, @AstraZeneca & @10xGenomics. #molpath
Federico Monzon retweeted
#AMPath21 Digital Experience today @PGDx @CanexiaHealth #MachineLearning @AstraZeneca @10xGenomics #lymphoma @AMPath business meeting
Federico Monzon retweeted
Did I do this correctly?
Types of #Pathology Paper.
PS: Many Thanks to @g_levrier for the @xkcd paper generator.
Federico Monzon retweeted
For something that is such a vital and integral part of #PatientCare why are #MolPath #MolDx efforts not adequately reimbursed under current payer systems? amp.org/AMP/assets/File/advo…
Federico Monzon retweeted
Wow this is huge! #Everlywell Acquires PWNHealth and Home Access Health Corporation, Forming Everly Health prnewswire.com/news-releases…
Federico Monzon retweeted
AMP commends the decision by the U.S. Department of Health and Human Services (HHS) to rescind the requirement for premarket review of laboratory developed testing procedures by the Food and Drug Administration (FDA): ow.ly/zaIR50B5z4X
Federico Monzon retweeted
👏👏An important and insightful editorial from @AMPath member @kaulk16 on #Covid_19 laboratory response and needs during a #pandemic – at Bethesda, MD
"Laboratories and pandemic preparedness: A framework for collaboration and oversight". A new Guest Editorial from former @JMDiagn Editor in Chief @kaulk16 now available as an Article in Press. Read for FREE: jmd.amjpathol.org/article/S1… #COVID19 #pandemic
Federico Monzon retweeted
Jordan Laser, AMP Professional Relations Committee Chair, said,"[The] entire global supply chain is strained right now due to both an overwhelming demand for materials and required diagnostic testing capacity around the world." #molpath #COVID19 #IDTwitter
It's been four months since the first reported case of #SARSCoV2 in the US. So why do we remain so far behind on testing?
bit.ly/2YUndtI
Federico Monzon retweeted
Thank you to AMP member @DrNetto for highlighting the important role of lab professionals testing for #COVID19! We're thankful to everyone working on the front lines of this pandemic to test patients. #molpath
Pathologists at the University of Alabama at Birmingham have been a crucial part of battling the COVID-19 pandemic in Alabama. uab.edu/news/health/item/112… @UABSOM @UABNews @uabmedicine @DrNetto
Federico Monzon retweeted
We’ll see more shortages of diagnostic tests if the FDA has its way statnews.com/2020/04/15/diag… via @statnews
Federico Monzon retweeted
UPDATE: The CAP continues urging Congress to stop steep Medicare cuts to pathologists in 2021. Just moments ago, the CAP and several physician and provider organizations sent the letter below to congressional leaders asking them to take action.
Federico Monzon retweeted
“There is a misconception that you only need a PCR machine and a PhD — that is 10% of what you need”... @AMPath, @Pathologists, @ACLPS_, @_AACC, & @ASMicrobiology have the scientific, medical, logistical, and ops expertise for #COVID19 #SARSCOV2 testing. buff.ly/2UYCgjF
Federico Monzon retweeted
One bill says its valid for @US_FDA to have oversight of LDTs, but a bill introduced today says its vital that the agency not be allowed to set the rules for such tests @ACLAlabs @AMPath @Pathologists
bit.ly/2UbbLpi
Federico Monzon retweeted
AMP applauds US Senator @RandPaul for introducing new legislation to allow molecular pathology professionals to continue advancing and offering laboratory developed testing procedures (LDPs) for patient care. #COVID19 amp.org/AMP/assets/File/pres…
Federico Monzon retweeted
We’ve come a long way baby!!!
This Post is from an account that no longer exists. Learn more
Federico Monzon retweeted
If you engage in clinical #NGS somatic variant analysis, interpretation, and reporting, your input is VITAL! Weigh in on the 2017 somatic variant classification system set by AMP, @ASCO & @Pathologists by November 15: ow.ly/RefO50wn1aP
#pathologists #molpath
Federico Monzon retweeted
Who’s AMPed for another great day of education? #AMPath19 @DNARNADan @Molecular_MD @olytic @roysomak4 @prattvm1 @GenomicPath @gizbab
































